An award-winning cannabis podcast for women, by women. Hear joyful stories and useful advice about cannabis for health, well-being, and fun—especially for needs specific to women like stress, sleep, and sex. We cover everything from: What’s the best weed for sex? Can I use CBD for menstrual cramps? What are the effects of the Harlequin strain or Gelato strain? And, why do we prefer to call it “cannabis” instead of “marijuana”? We also hear from you: your first time buying legal weed, and how ...
…
continue reading
Kandungan disediakan oleh The Radcliffe Cardiology Podcast. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The Radcliffe Cardiology Podcast atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
View from the Thoraxcenter: TCT 24 Late-breaking Science Wrap Up
MP3•Laman utama episod
Manage episode 452376456 series 2990303
Kandungan disediakan oleh The Radcliffe Cardiology Podcast. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The Radcliffe Cardiology Podcast atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the latest data for practice and for research. Trials covered in detail include: ECLIPSE (00:49 - 05:55) FAVOR III (05:55 - 10:30) FLASH (10:30 - 12:54) DCB BIFURCATION (12:54 - 15:17) EARLY TAVR (15:17 - 21:14) EVOLVED (21:14 - 24:07) TAVR-UNLOAD (24:07 - 28:57) PEERLESS (28:57 - 31:14) CLEAR IE (31:14 - 33:29) TRISCEND II (33:29 - 36:36) ACCESS TAVI (36:36 - 40:05) ALIGN AR (40:05 - 41:49) COSTAR RCT (41:49 - 43:36) ACURATE IDE (43:36 - 46:42) CLEAR SYNERGY(46:42 - 48:41) This is an independent interview produced by Radcliffe Cardiology.
…
continue reading
49 episod
MP3•Laman utama episod
Manage episode 452376456 series 2990303
Kandungan disediakan oleh The Radcliffe Cardiology Podcast. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh The Radcliffe Cardiology Podcast atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the latest data for practice and for research. Trials covered in detail include: ECLIPSE (00:49 - 05:55) FAVOR III (05:55 - 10:30) FLASH (10:30 - 12:54) DCB BIFURCATION (12:54 - 15:17) EARLY TAVR (15:17 - 21:14) EVOLVED (21:14 - 24:07) TAVR-UNLOAD (24:07 - 28:57) PEERLESS (28:57 - 31:14) CLEAR IE (31:14 - 33:29) TRISCEND II (33:29 - 36:36) ACCESS TAVI (36:36 - 40:05) ALIGN AR (40:05 - 41:49) COSTAR RCT (41:49 - 43:36) ACURATE IDE (43:36 - 46:42) CLEAR SYNERGY(46:42 - 48:41) This is an independent interview produced by Radcliffe Cardiology.
…
continue reading
49 episod
Tutti gli episodi
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.